Stay updated on Stereotactic RT+Pembrolizumab in Oligometastatic Renal Cancer Clinical Trial

Sign up to get notified when there's something new on the Stereotactic RT+Pembrolizumab in Oligometastatic Renal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Stereotactic RT+Pembrolizumab in Oligometastatic Renal Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page now displays revision v3.6.6, replacing v3.6.5. This reflects a site maintenance update rather than substantive changes to study content.
    Difference
    0.1%
    Check dated 2026-08-29T20:07:56.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.6.4 to v3.6.5, representing a version bump. There are no visible changes to the study details or content.
    Difference
    0.1%
    Check dated 2026-08-08T19:39:24.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The site’s revision tag changed from v3.6.3 to v3.6.4 to reflect an update.
    Difference
    0.1%
    Check dated 2026-07-25T12:27:23.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The page shows a new revision tag (v3.6.3), signaling a backend update; this change does not appear to affect the study details displayed.
    Difference
    0.1%
    Check dated 2026-07-03T23:18:31.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    The page now displays a newer site revision label (v3.6.2) replacing the previous v3.6.0, indicating a software release for the page. This update does not alter the study details, eligibility criteria, or results displayed on the page.
    Difference
    0.1%
    Check dated 2026-06-26T23:59:34.000Z thumbnail image
  9. Check
    93 days ago
    Change Detected
    Summary
    The study page now shows that no participants are being sought, updating the recruitment status to completed. Additionally, new help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and a small formatting change updated the Intervention/Treatment label while the site revision progressed from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T16:38:27.000Z thumbnail image

Stay in the know with updates to Stereotactic RT+Pembrolizumab in Oligometastatic Renal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Stereotactic RT+Pembrolizumab in Oligometastatic Renal Cancer Clinical Trial page.